Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen To Raise GBP1.4 Million To Double Labskin Laboratory Size

Mon, 09th Dec 2019 14:56

(Alliance News) - Integumen PLC said on Monday it intends to raise GBP1.4 million to provide working capital to help deliver revenue growth for 2020.

Shares in Integumen were flat at 1.56 pence each on Monday in London, giving it a market capitalisation of GBP15.3 million.

The AIM-listed personal healthcare company will issue 91.3 million at a price of 1.5 pence per share, with the funds to go towards doubling the size of the Labskin AI laboratory in York, England.

Integumen said it intends to hire additional laboratory, sales & data scientists, and increasing average sales per client to between GBP100,000 and GBP500,000 for physical & artificial intelligence services.

Labskin AI's technology platform allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment.

The funding will also help to engage technical support professionals to support Rinodrive and its intelligent data management and analytics software services. Rinodrive is an AI analysis system that provides insight that supports clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

Gerard Brandon, chief executive officer, said: "It is necessary for the company to provide verifiable assurances during a client's due diligence process that its cash buffer is strong throughout the duration of each client's engagement with the company. The monies raised will provide this buffer and enable this continued rapid growth of sales to many leading global skincare companies through the expansion of both facilities and employees."

In the nine months ended September 30, Integumen achieved a turnover of GBP591,000 compared with the same period last year when the turnover was GBP116,000. The company reported an loss before interest, taxes, depreciation, and amortization of GBP668,000, a reduction of GBP134,000 on the comparative period in 2018.

Overheads totalled GBP1.129 million, an increase of GBP249,000 year-on-year. As at September this year, the company had cash balances of GBP477,000, it said.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
30 Sep 2020 17:10

Integumen enters deal with Detroit water quality non-profit

(Sharecast News) - Integumen has signed a memorandum of understanding with Detroit-based non-profit organisation Water Rising Institute, it announced on Wednesday, to enter a legally-binding three-year framework agreement.

Read more
25 Sep 2020 10:32

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

Read more
25 Sep 2020 10:21

Integumen And Modern Water Get Publication Date Extension For Merger

Integumen And Modern Water Get Publication Date Extension For Merger

Read more
18 Sep 2020 14:23

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

Read more
28 Aug 2020 13:20

Integumen agrees deal to take over Modern Water

(Sharecast News) - Integumen and Modern Water have reached agreement on the terms of a recommended offer to be made by Integumen for the entire issued and to be issued share capital of Modern Water, they announced on Friday.

Read more
28 Aug 2020 10:47

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Read more
29 Jul 2020 21:19

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

Read more
29 Jul 2020 13:53

Integumen secures £3m loan to fund Covid-19 AI goals

(Sharecast News) - Integumen announced on Wednesday that it has secured a £3m, three-year loan facility with Riverfort Global Opportunities and YA II PN.

Read more
24 Jul 2020 15:37

Integumen's Labskin launches remote clinical trials platform

(Sharecast News) - Integumen announced on Friday that its subsidiary Labskin was launching its remote clinical skin trials platform, which it claimed was the world's first of its type.

Read more
24 Jul 2020 13:56

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

Read more
13 Jul 2020 11:23

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Read more
13 Jul 2020 09:18

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

Read more
23 Jun 2020 06:47

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

Read more
22 Jun 2020 16:36

Integumen signs deal for Covid-19 detection in wastewater

(Sharecast News) - Integumen has signed a material transfer agreement with the Aptamer Group, it announced on Monday, to develop and manufacture aptamers to detect SARS-CoV-2, or Covid-19, in wastewater.

Read more
15 Jun 2020 13:54

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.